New findings from the FACEHBI study show that baseline amyloid PET scans in people with subjective cognitive decline can ...

A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to its previously unknown secondary function that triggers a pathway that ...

Researchers have discovered that a gene previously seen as a biomarker for Alzheimer’s disease, PHGDH, actually plays a ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...

Panelists discuss how hesitancy in prescribing amyloid-targeting therapies stems ... and Implementation of Disease-Modifying Therapies in Alzheimer Disease ...

Alzheon’s con­tro­ver­sial, decade-long bet that a failed Alzheimer’s drug could of­fer big­ger ben­e­fits to a sub­set of pa­tients at the high­est risk for the dis­ease … ...

The much-awaited new Aadhaar app Beta version has been rolled out by the central government, a promising move to make Aadhaar more accessible and secure. Union Minister of Electronics and ...

Additionally, there is some evidence that these drugs can reduce levels of amyloid-beta and tau proteins in the brain — the hallmarks of Alzheimer’s disease. Speaking with the Science Media ...

MTBR-tau243 may also improve our confidence in ruling in or out a diagnosis of Alzheimer’s disease in symptomatic patients — particularly older patients in whom biomarkers of amyloid alone ...

BUFFALO, N.Y. — According to the Alzheimer's Association, nearly 7 million Americans have Alzheimer's disease. Now, a new blood test is offering hope after a study showed it not only helps ...

While misfolded SOD1 proteins (among others) cause ALS, misfolded amyloid beta oligomers cause Alzheimer's disease. "These are good proteins gone bad," Klein said. "They are good proteins ...